NS 2664

Drug Profile

NS 2664

Latest Information Update: 13 Jul 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NeuroSearch
  • Class Antiepileptic drugs; Neuroprotectants
  • Mechanism of Action GABA-A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Complex partial epilepsy

Most Recent Events

  • 13 Jul 2006 Discontinued - Preclinical for Complex partial seizures in Denmark (unspecified route)
  • 03 Dec 2003 A preclinical study has been added to the Epilepsy pharmacodynamics section
  • 27 Nov 2003 Preclinical trials in Complex partial seizures in Denmark (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top